prednisone has been researched along with Adrenal Gland Hyperfunction in 32 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We measured [125I]insulin binding to circulating monocytes or erythrocytes from 16 patients with chronic glucocorticoid excess, 9 chronically treated with prednisone and 7 with adrenocortical hyperfunction." | 3.66 | Effects of chronic glucocorticoid excess in man on insulin binding to circulating cells: differences between endogenous and exogenous hypercorticism. ( Muggeo, M; Roth, J; Saviolakis, A; Wachslicht-Rodbard, H, 1983) |
| "A retrospective study was made of 16 children with 21-hydroxylase-deficient congenital adrenal hyperplasia of the salt-losing variety, who were treated with fludrocortisone and prednisone and were in good health during the period under review." | 3.66 | Management of congenital adrenal hyperplasia. Urinary steroid estimations--review of their value. ( Bailey, CC; Komrower, GM; Palmer, M, 1978) |
| "All patients were treated with GCs and responded rapidly (median initial dosage 60 mg prednisone/day)." | 1.32 | Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. ( Gabriel, SE; Hunder, GG; O'Fallon, WM; Orces, C; Proven, A, 2003) |
| " To clarify this apparent disparity and to determine if glucocorticoid stimulation can augment GH release in man after direct pituitary stimulation with GHRH, we administered 1 microgram/kg GHRH dosage to seven normal men before and after a 4-day course of prednisone (20 mg, orally, three times daily)." | 1.27 | Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men. ( Culler, FL; Jones, KL; Kaufmann, S; Wehrenberg, WB, 1988) |
| "Aldosterone was not produced in the patient and the metabolic product of its immediate precursor, 18-hydroxy-11-dehydro-tetrahydrocorticosterone, was excreted in markedly elevated amounts." | 1.26 | 17 alpha-Hydroxylase deficiency. A combination of hydroxylation defect and reversible blockade in aldosterone biosynthesis. ( Berlinger, FG; Cohen, EL; Conn, JW; Gordon, DL; Kem, DC; Rovner, DR, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (84.38) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 2 (6.25) | 29.6817 |
| 2010's | 2 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muñoz, J | 1 |
| Soblechero, P | 1 |
| Duque, FJ | 1 |
| Macías-García, B | 1 |
| Ruiz, P | 1 |
| Zaragoza, C | 1 |
| Barrera, R | 1 |
| Romão, FG | 1 |
| Campos, EF | 1 |
| Mattoso, CR | 1 |
| Takahira, RK | 1 |
| SKOOG, WA | 1 |
| ADAMS, WS | 1 |
| STAFFIERI, JJ | 2 |
| LENCIONI, LJ | 1 |
| BERLI, RR | 1 |
| WAIS, S | 1 |
| CAINO, HV | 1 |
| CABARROU, A | 1 |
| BIANCHI, NO | 1 |
| PINTADO, O | 1 |
| MENTHA, C | 1 |
| COOKSON, BA | 1 |
| GILBOA, Y | 1 |
| RUMNEY, G | 1 |
| BER, A | 1 |
| CARDONNET, LJ | 1 |
| EBERHARDT, DR | 1 |
| Proven, A | 1 |
| Gabriel, SE | 1 |
| Orces, C | 1 |
| O'Fallon, WM | 1 |
| Hunder, GG | 1 |
| Peta, HG | 1 |
| Carr, AP | 1 |
| Myers, SL | 1 |
| Joffe, DJ | 1 |
| Kidney, BA | 1 |
| Muggeo, M | 1 |
| Saviolakis, A | 1 |
| Wachslicht-Rodbard, H | 1 |
| Roth, J | 1 |
| Behrend, EN | 1 |
| Kemppainen, RJ | 1 |
| Clark, TP | 1 |
| Salman, MD | 1 |
| Peterson, ME | 1 |
| Maclaren, NK | 1 |
| Migeon, CJ | 2 |
| Raiti, S | 1 |
| Rovner, DR | 1 |
| Conn, JW | 1 |
| Cohen, EL | 1 |
| Berlinger, FG | 1 |
| Kem, DC | 1 |
| Gordon, DL | 1 |
| Bailey, CC | 1 |
| Komrower, GM | 1 |
| Palmer, M | 1 |
| Huseman, CA | 1 |
| Varma, MM | 1 |
| Blizzard, RM | 2 |
| Johanson, A | 1 |
| Klingensmith, GJ | 1 |
| Garcia, SC | 1 |
| Jones, HW | 1 |
| Klein, RG | 1 |
| Arnaud, SB | 1 |
| Gallagher, JC | 1 |
| Deluca, HF | 1 |
| Riggs, BL | 1 |
| Horner, JM | 1 |
| Thorson, AV | 1 |
| Hintz, RL | 1 |
| Etienne, SD | 1 |
| Chosidow, O | 1 |
| Herson, S | 1 |
| Kaufmann, S | 1 |
| Jones, KL | 1 |
| Wehrenberg, WB | 1 |
| Culler, FL | 1 |
| Akoun, G | 1 |
| Vachon, J | 1 |
| Muon, N | 1 |
| Brocard, H | 1 |
| Clayton, BE | 1 |
| Edwards, RW | 1 |
| Makin, HL | 1 |
| Franks, RC | 1 |
| Kenny, FM | 1 |
| Bozkowa, K | 1 |
| Raczyńska, B | 1 |
| Kamińska-Sliwińska, M | 1 |
| Sielicka-Gracka, M | 1 |
| Brook, CG | 1 |
| Zachmann, M | 1 |
| Prader, A | 1 |
| Mürset, G | 1 |
| Liberman, B | 1 |
| Wajchenberg, BL | 1 |
| Mohrer, EF | 1 |
| Bicknell, EJ | 1 |
| Wierzchowiecki, M | 1 |
| Witoszyński, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Biomarkers in Giant Cells Arteritis[NCT02844023] | 100 participants (Actual) | Interventional | 2015-01-31 | Terminated (stopped due to recruitment failure) | |||
| A Randomized, Controled, Open Label Trial: Comparison Between Two Standardized Corticosteroids Tapering, Respectively Short (North American) and Long (European), in Giant Cell Arteritis[NCT04012905] | Phase 3 | 150 participants (Anticipated) | Interventional | 2020-11-05 | Not yet recruiting | ||
| Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission: a Prospective, Pilot Study.[NCT03244709] | Phase 4 | 15 participants (Anticipated) | Interventional | 2015-01-01 | Recruiting | ||
| A Phase II Study of Oral Calcitriol in Combination With Ketoconazole in Castration Resistant Prostate Cancer, Progressing Despite Primary ADT and Abiraterone[NCT03261336] | Phase 2 | 1 participants (Actual) | Interventional | 2017-01-06 | Terminated (stopped due to can not meet enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Descriptive analysis of observed toxicity and patient reports of tolerating experimental treatment (NCT03261336)
Timeframe: 2 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Calcitriol, Ketoconazole, Hydrocortisone | 1 |
1 review available for prednisone and Adrenal Gland Hyperfunction
| Article | Year |
|---|---|
[Corticoids. Pharmacology and therapeutics].
Topics: Adrenal Insufficiency; Adrenocortical Hyperfunction; Animals; Drug Interactions; Glucocorticoids; Hu | 1989 |
2 trials available for prednisone and Adrenal Gland Hyperfunction
| Article | Year |
|---|---|
Hemostatic profile and thromboembolic risk in healthy dogs treated with prednisone: a randomized controlled trial.
Topics: Adrenocortical Hyperfunction; Animals; Anti-Inflammatory Agents; Bleeding Time; Blood Cell Count; Do | 2013 |
Effect of serum storage, anti-inflammatory oral doses of prednisone, and spontaneous hyperadrenocorticism on serum glutamate dehydrogenase activity in dogs.
Topics: Administration, Oral; Adrenocortical Hyperfunction; Animals; Anti-Inflammatory Agents; Dermatitis; D | 2007 |
29 other studies available for prednisone and Adrenal Gland Hyperfunction
| Article | Year |
|---|---|
Effects of Oral Prednisone Administration on Serum Cystatin C in Dogs.
Topics: Administration, Oral; Adrenocortical Hyperfunction; Animals; Anti-Inflammatory Agents; Arteritis; Cy | 2017 |
Metabolic balance study in a case of virilizing adrenal hyperplasia treated with prednisone.
Topics: Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenogenital | 1957 |
[Effect of prednisone & prednisolone on adrenocortical androgenic hyperfunction].
Topics: Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenogenital Syndrome; Androgens; Pr | 1957 |
[Use of prednisone in adrenal cortical hyperfunction].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Prednisone | 1958 |
[Adrenogenital syndrome due to adrenal hyperplasia].
Topics: Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenogenital | 1958 |
[ARE CORTISONE DERIVATIVES RESPONSIBLE FOR ACUTE ARTERIAL OBLITERATION?APROPOS OF 2 CASES].
Topics: Adrenal Cortex Hormones; Adrenocortical Hyperfunction; Angiography; Arteries; Arteriosclerosis Oblit | 1963 |
KORSAKOFF'S SYNDROME ASSOCIATED WITH ADRENAL VIRILISM.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfun | 1964 |
"VIRILIZING" ADRENAL HYPERPLASIA IN AN ELDERLY MAN; ASSOCIATION WITH CHRONIC FATIGUE AND FEVER.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenoc | 1964 |
[ENDOCRINOLOGICAL STUDY ON THE USE OF NIALAMIDE AS A COADJUVANT IN CORTICOSTEROID THERAPY].
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocortical Hyperfunction; Biomedical Research; Drug Therapy | 1964 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Effects of chronic glucocorticoid excess in man on insulin binding to circulating cells: differences between endogenous and exogenous hypercorticism.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Blood Cells; Erythrocytes; Female; Glucocorticoids; | 1983 |
Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; | 1999 |
Gynecomastia with congenital virilizing adrenal hyperplasia (11-beta-hydroxylase deficiency).
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Function Tests; Adrenal Hyperplasia, Cong | 1975 |
17 alpha-Hydroxylase deficiency. A combination of hydroxylation defect and reversible blockade in aldosterone biosynthesis.
Topics: 18-Hydroxycorticosterone; Adolescent; Adrenal Cortex Hormones; Adrenal Glands; Adrenocortical Hyperf | 1979 |
Management of congenital adrenal hyperplasia. Urinary steroid estimations--review of their value.
Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Body Height; Child; | 1978 |
Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone.
Topics: 17-Ketosteroids; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Child; C | 1977 |
Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility.
Topics: 17-Ketosteroids; Adolescent; Adrenocortical Hyperfunction; Body Height; Breast; Child; Child, Presch | 1977 |
Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
Topics: Adrenocortical Hyperfunction; Adult; Alkaline Phosphatase; Calcium; Calcium, Dietary; Dihydroxychole | 1977 |
Prednisone in the therapy of congenital adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Bone and Bones; Bone Development; Gro | 1977 |
Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men.
Topics: Adrenocortical Hyperfunction; Adult; Blood Glucose; Child; Growth Hormone; Growth Hormone-Releasing | 1988 |
[Prescription of corticotherapy on alternate days for long periods].
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenocortical Hyperfunct | 1968 |
Congenital adrenal hyperplasia and other conditions associated with a raised urinary steroid 11-oxygenation index.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfunction; Adrenocorticotrop | 1971 |
Plasma 17-hydroxyprogesterone, 21-deoxycortisol and cortisol in congenital adrenal hyperplasia.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenocorticotropic Hormo | 1974 |
Use of corticosteroids.
Topics: Addison Disease; Administration, Oral; Adolescent; Adrenocortical Hyperfunction; Age Factors; Asthma | 1974 |
[Attempt at differentiating congenital adrenal hyperplasia in children by thin-layer chromatography (author's transl)].
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction | 1973 |
Experience with long-term therapy in congenital adrenal hyperplasia.
Topics: 17-Ketosteroids; Adolescent; Adrenocortical Hyperfunction; Body Height; Bone Development; Child; Chi | 1974 |
Exchangeable potassium in states of adrenocortical dysfunction and in induced hypercortisonism.
Topics: Addison Disease; Adolescent; Adrenal Glands; Adrenal Insufficiency; Adrenocortical Hyperfunction; Ad | 1971 |
Congenital adrenal hyperplasia and diabetes mellitus in a woman aged 71 years.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfun | 1972 |
[Our expeiences in treatment of patients with systemic lupus erythematosus with steroids].
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Cortisone; Female; Humans; Lupus Erythematosus, Sys | 1968 |